Stock Markets: Nasdaq

EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis

WALTHAM, Mass., April 06, 2018 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), today announced completion of patient enrollment for the pivotal Phase 3 clinical study of its EGP-437 combination product for the treatment of non-infectious anterior uveitis.Non-infectious anterior uveitis is characterized by the inflammation of the anterior chamber of the eye. Symptoms may include redness, soreness and inflammation of the eye, blurring of vision, sensitivity to light...

Published on .

THE NEW PONSSE FOX – FOR AGILE AND EFFICIENT THINNING

 THE NEW PONSSE FOX – FOR AGILE AND EFFICIENT THINNINGPONSSE Fox Harvester is a fuel-efficient and productive combination of state-of-the-art technology and reliable basic solutions. The driving forces of the Fox are the accurate and powerful crane, good visibility, machine stability and low surface pressure for demanding conditions and soft grounds.PONSSE Fox – unbeatable agility and powerThe eight-wheeled PONSSE Fox is tailor-made for thinning and soft grounds. The crane is powerful and...

Published on .

AstroNova Announces First Commercial Shipments of Trojan™ T4

WEST WARWICK, R.I.--(BUSINESS WIRE)--AstroNova, Inc. (NASDAQ: ALOT), a global leader in data visualization technologies, today announced the first shipments of its Trojan™ T4 digital color label press and finishing system to commercial customers in North America. “With its superior quality, high speed and significantly lower cost than competitive digital printing systems, the Trojan T4 from TrojanLabel™ is truly game-changing technology that enables small- to mid-sized commercial printers to...

Published on .

Biocept to Webcast Presentation at the 7th Annual MicroCap Conference

SAN DIEGO, April 6, 2018 -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that President and CEO Michael W. Nall will present a corporate overview at the 7th Annual MicroCap Conference. The conference will be held on April 9-10 in New York City. A live webcast of the corporate presentation will be available...

Published on .

Silicon Labs Announces First Quarter 2018 Earnings Webcast

AUSTIN, Texas, April 6, 2018 -- Silicon Labs (NASDAQ: SLAB), a leading provider of silicon, software and solutions for a smarter, more connected world, today announced that it plans to release first quarter 2018 financial results on Wednesday, April 25, 2018. An earnings conference call will follow the release at 7:30 a.m. Central Time. The call will be webcast from the Investor Relations section of the company website at www.silabs.com. A replay will be available after the call on the...

Published on .

PriceSmart, Inc. Announces New Chief Financial Officer

SAN DIEGO, April 6, 2018 -- PriceSmart Inc. (NASDAQ: PSMT) today announced the appointment of Maarten Jager as Executive Vice President and Chief Financial Officer effective April 24, 2018.  Mr. Jager will replace John M. Heffner who has served in that role since January 2004 and had previously announced his plans to retire from the Company. Mr. Jager currently serves as Senior Vice President of Walmart International, a segment of Walmart Inc., where he has worked since 2014.  During...

Published on .

EROAD Increases Supply Chain Visibility Through Integration with Descartes MacroPoint

With EROAD and Descartes MacroPoint integrations shippers now have full in-transit visibility “Real-time load tracking is an integral part of having end-to-end supply chain visibility,” said Scott McCollister, senior product manager at EROAD. PORTLAND, Ore. April 06, 2018 EROAD platform allows carriers to improve delivery performance and customer satisfaction through integration with Descartes MacroPoint EROAD, a global technology provider of fleet management, electronic tax reporting...

Published on .

Adaptimmune to Present Two Posters at the Upcoming American Association for Cancer Research (AACR) Annual Meeting

PHILADELPHIA, Pa. and OXFORD, U.K., April 06, 2018 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will present two posters summarizing preclinical research with its MAGE-A4 and MAGE-A10 SPEAR T-cells at the upcoming AACR meeting at McCormick Place in Chicago, Illinois.Session, date, time, and location (for both posters):Session Category (Title): Clinical Research (Adoptive Cell Therapy 2)Date: Monday Apr 16, 2018Time: 1:00 PM - 5:00 PM (CDT)Location:...

Published on .

Tyme and JAF Announce Sarcoma Treatment Collaboration

NEW YORK, April 06, 2018 -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company, today announced that it is collaborating with The Joseph Ahmed Foundation (“JAF”) to provide treatment for metastatic sarcomas. The collaboration will focus on children and young adults with bone or soft tissue sarcomas, with an initial focus on Ewing's sarcoma. Sarcomas are rare forms of cancer that have poor prognosis at the metastatic stage, with most treatment options demonstrating limited...

Published on .

Fejl i indberetning af indre værdi for udvalgte andelsklasser i Sparinvest SICAV

Under henvisning til Nasdaq Copenhagen A/S´ regler for udstedere af investeringsbeviser, skal Sparinvest S.A. på vegne af Sparinvest SICAV meddele, at den offentliggjorte indre værdi på nedenstående andelsklasser har været forkert fastsat ved prisudsendelse den 3. april 2018 kl. 09:42 og frem til kl. 13:22 samme dag, hvor den indre værdi blev korrigeret.Indre værdi har været forkert beregnet for følgende andelsklasser:Der har i perioden for fejlberegningen ikke været emissioner eller indløsninger...

Published on .

Fejl i indberetning af indre værdi for en enkelt afdeling i Værdipapirfonden Sparindex

Under henvisning til lov om investeringsforeninger m.v. § 75, stk. 1, samt Nasdaq Copenhagen A/S´ regler for udstedere af investeringsbeviser, skal ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg på vegne af Værdipapirfonden Sparindex meddele, at den offentliggjorte indre værdi på nedenstående afdeling har været forkert fastsat ved prisudsendelse den 3. april 2018 kl. 09:42 og frem til kl. 13:22 samme dag, hvor den indre værdi blev korrigeret.Indre værdi har været forkert beregnet...

Published on .

Fejl i indberetning af indre værdi for udvalgte afdelinger/andelsklasser i Investeringsforeningen Sparinvest

Under henvisning til lov om investeringsforeninger m.v. § 75, stk. 1, samt Nasdaq Copenhagen A/S´ regler for udstedere af investeringsbeviser, skal ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg på vegne af Investeringsforeningen Sparinvest meddele, at den offentliggjorte indre værdi på nedenstående afdelinger/andelsklasser har været forkert fastsat ved prisudsendelse den 3. april 2018 kl. 09:42 og frem til kl. 13:22 samme dag, hvor den indre værdi blev korrigeret.Indre værdi har været...

Published on .

Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)

BRIDGEWATER, N.J., April 6, 2018 -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has launched a generic version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%).  Impax's manufacturing and development partner, Perrigo Company plc (NYSE; TASE: PRGO), received final approval from the U.S. Food and Drug Administration in late January.  Estrace® Cream had annual U.S. sales of approximately $469 million according to IQVIA®...

Published on .

Qualcomm Extends Cash Tender Offer for All Outstanding Shares of NXP

SAN DIEGO, April 6, 2018 -- Qualcomm Incorporated (NASDAQ: QCOM) today announced that Qualcomm River Holdings B.V., an indirect wholly owned subsidiary of Qualcomm, has extended the offering period of its previously announced cash tender offer to purchase all of the outstanding common shares of NXP Semiconductors N.V. (NASDAQ: NXPI). The tender offer is being made pursuant to the Purchase Agreement, dated as of October 27, 2016, by and between Qualcomm River Holdings B.V. and NXP, as amended (the...

Published on .

Federal District Court Rules in Favor of Axon in PhaZZer Infringement Suit

SCOTTSDALE, Ariz., April 6, 2018 -- Axon (Nasdaq: AAXN), the global leader in connected law enforcement technologies, today announced that a Florida federal district court has ruled in favor of Axon against PhaZZer Electronics, Inc. for its willful infringement of Axon's patent and trademark rights concerning its sale of the PhaZZer Enforcer CEW (conducted electrical weapon) and probe cartridges. The award follows the court's judgment and permanent injunction issued in July...

Published on .

Mylan Strengthens Its Capital Structure by Extending Its Debt Maturities with a Successful $1.5 Billion Bond Offering

HERTFORDSHIRE, England and PITTSBURGH, April 6, 2018 -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the pricing of a private offering of $1.5 billion aggregate principal amount of senior notes on March 28, 2018, comprised of: $750 million aggregate principal amount of 4.550% Senior Notes due 2028; and $750 million aggregate principal amount of 5.200% Senior Notes due 2048 (collectively, the "Notes"). The Notes will be issued by Mylan Inc. and guaranteed by...

Published on .